Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CRMD
#2460
CorMedix Inc.
7.130
0
-1.79%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
-1.79%
Monthly Change
-8.24%
6 month change
-36.90%
Cambio anual
-36.90%
Cierres anteriores
7.260
0
Open
7.130
0
Bid
Ask
Low
7.130
0
High
7.130
0
Volumen
99
Markets
Acciones
Atención Sanitaria
CRMD
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
60.68 M
65.18 M
67.82 M
74.65 M
78.79 M
—
Valuation ratios
Enterprise value
454.99 M
487.32 M
351.51 M
760.37 M
867.82 M
2.47 B
Price to earnings ratio
-10.1
-27
24.64
15.79
5.56
19
Price to sales ratio
38.71
10.97
4.72
6.68
4.07
26.44
Price to cash flow ratio
-8.18
-9.42
-21.6
32.79
12.04
13.81
Price to book ratio
1.93
5.63
1.26
1.72
1.11
9.71
Enterprise value to EBITDA ratio
-8.97
-22.1
23.39
15.2
7.75
24.24
Profitability ratios
Return on assets %
-0.04
0.11
0.14
0.08
0.14
0.47
Return on equity %
-0.05
0.16
0.18
0.09
0.29
0.72
Return on invested capital %
-146.64
221.48
225.66
223.32
142.32
812.79
Gross margin %
94.01
96.23
95.91
95.31
89.26
376.73
Operating margin %
-28.7
41.45
51.5
49.18
49.24
191.37
EBITDA margin %
-27.57
42.04
51.91
49.72
56.45
200.13
Net margin %
-24.24
43.14
52.82
49.9
104.11
249.97
Liquidity ratios
Quick ratio
3.6
3.16
3.99
7.52
1.73
16.4
Current ratio
3.96
3.39
4.21
7.82
1.94
17.36
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.17
0.32
0.29
0.2
0.21
1.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
0.39
—
Long term debt to total equity ratio
—
—
—
—
0.79
—
Per share metrics
Operating cash flow per share
-0.23
-0.1
0.29
0.42
0.36
0.97
EBIT per share
-0.06
0.22
0.29
0.27
0.64
1.42
EBITDA per share
-0.05
0.22
0.29
0.27
0.68
1.47
Total debt per share
—
—
—
—
—
—
Cash per share
0.78
0.88
1.12
2.65
0.65
5.3
Net current asset value per share
1.24
1.95
2.1
3.45
3.01
10.51
Tangible book value per share
0.97
1.41
1.64
3.04
-0.39
5.7
Working capital per share
0.93
1.37
1.6
3.01
1.46
7.44
Book value per share
1
1.44
1.67
3.07
4.34
10.51
Noticias
Cytek Biosciences, Inc. (CTKB) Reports Q4 Loss, Tops Revenue Estimates
CRMD vs. TBPH: Which Small-Cap Biotech Stock Is the Better Bet?
Should Investors Buy, Sell or Hold CRMD Stock Ahead of Q4 Earnings?
CorMedix Down 27% in 3 Months: Is It Time to Sell the Stock?
CorMedix Inc. (CRMD) Analyst/Investor Day Transcript
CorMedix Inc. (CRMD) Analyst/Investor Day - Slideshow (NASDAQ:CRMD) 2026-02-11
Citizens reitera calificación de Mejor Rendimiento para acciones de CorMedix
CorMedix Banks on DefenCath Sales in Q4 as Melinta Adds Upside
Las acciones de CorMedix suben tras anunciar un plan de recompra de 75 millones de dólares
Acciones de CorMedix suben tras anunciar plan de recompra por $75 millones
CorMedix stock rises after announcing $75 million share buyback plan
CorMedix anuncia programa de recompra de acciones por $75 millones